More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.41B
EPS
-23.65
P/E ratio
--
Price to sales
1.16
Dividend yield
--
Beta
1.7662
Previous close
$8.43
Today's open
$11.64
Day's range
$10.28 - $12.41
52 week range
$3.51 - $23.20
show more
CEO
Irwin D. Simon
Employees
2650
Headquarters
Leamington, ON
Exchange
Nasdaq Global Select
Shares outstanding
116147906
Issue type
Common Stock
Healthcare
Pharmaceuticals
Cannabis stocks surge on report Trump seeks to ease restrictions
Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to push the government to dramatically loosen federal restrictions on marijuana.
Reuters • Dec 12, 2025

Trump Just Reignited Weed Stocks — And Tilray's Vape Is Leading The Revival
Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc (NASDAQ: TLRY) vape launch so successful it broke the internal math of the company's own product mix.
Benzinga • Dec 12, 2025

Why Tilray Stock Lit Up Today
Reports indicate the President will instruct federal agencies to make marijuana a Schedule III drug soon. This isn't "legalization" per se, but it will make marijuana a bit more "legal.
The Motley Fool • Dec 12, 2025

Tilray's stock takes off on hope that cannabis will soon be treated more like steroids than heroin
Tilray's stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than it is now.
Market Watch • Dec 12, 2025

Tilray stock price pumps after latest Trump cannabis reclassification news
Tilray Brands stock price has rebounded in the past three days, and chances are that the surge will accelerate as a new catalyst emerges. TLRY rose to $8.43, a few days after the company completed its reverse stock split.
Invezz • Dec 12, 2025

Tilray Stock Soars on Reclassification Buzz
Tilray Brands Inc (NASDAQ:TLRY) stock is soaring today, after the Washington Post reported that U.S. President Donald Trump plans to reclassify marijuana and dramatically loosen restrictions.
Schaeffers Research • Dec 12, 2025

Cannabis stocks surge on reports Trump will reclassify marijuana; Tilray jumps 28%
President Donald Trump will significantly ease federal restrictions on marijuana and change its classification, according to the Washington Post and Axios. Cannabis stocks surged following the report.
CNBC • Dec 12, 2025

Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.
CNBC Television • Dec 12, 2025

Cannabis stocks rally on reports Pres. Trump will sign executive order reclassifying marijuana
'Fast Money' trader Tim Seymour talks the jump in cannabis stocks on reclassification rumors.
CNBC Television • Dec 12, 2025

Cannabis stocks surge on report Trump seeks to ease restrictions.
President Donald Trump is expected to push for marijuana reclassification from Schedule I to Schedule III status, sending cannabis stocks soaring.
Fox Business • Dec 12, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Tilray Brands Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.